Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan

• Main Authors: Dana Dadanbekova (Author), Kairat Zhakipbekov (Author), Almat Kodasbayev (Author), Ubaidilla Datkhayev (Author), Guenka Petrova (Author), Konstantin Tachkov (Author)
• Format: Book
• Published: Pensoft Publishers, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The objective of this study is to evaluate the quality of life (QoL) of hospitalised patients with cardiomyopathy (CM) treated with a fixed dose combination (FDC) of sacubitril/valsartan, or standard therapy in Kazakhstan during or after COVID-19. This is an observational study of patients with inci...